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Background: Healing of skin wound is a multi-factorial and complex process. Treatment of diabetic
wounds is still a major clinical challenge. Recently, stem cell transplantation to chronic wounds is
favored. The objective of this study was to evaluate effects of pre-labeled allogenous skin ﬁbroblasts on
healing of ovine diabetic wound model.
Methods: Eight 4-month-old Iranian Makoui wethers were used in this study. Alloxan monohydrate was
used for induction of diabetes. In each wether two excisional wound were created on dorsum of the
animal. Wounds of one side were randomly chosen as treatment group (n ¼ 8), and wounds of the other
side were considered as control group (n ¼ 8). Pre-labeled skin ﬁbroblasts with bromodeoxyuridine were
used in wounds of one side as treatment. Photographs were taken in distinct times for planimetric
evaluation. Wound samples were taken for BrdU detection and histopathologic evaluations on day 21
post-wounding.
Results: The planimetric study showed closure of ﬁbroblast treated wounds is signiﬁcantly faster than
control group (P < 0.05). Immunohistochemical staining with anti-bromodeoxyuridine antibody indi-
cated presence of transplanted cells in the wounds. Histopathologic evaluations of H&E stained sections
disclosed signiﬁcantly increasing of re-epithelialization, number of ﬁbroblasts, and number of blood
vessels in treatment group in comparison to control group (P < 0.05).
Conclution: The results of this study indicated that allogenous skin ﬁbroblast transplantation can posi-
tively affect wound healing in diabetic sheep.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Healing of skin wound is a multi-factorial and complex process
[1]. Among these, treatment of chronic wounds, especially inemi@urmia.ac.ir (S. Kazemi-
by Elsevier Ltd. All rights reserveddiabetic patients, is a major clinical challenge [2]. The full mech-
anisms of impaired wound healing in diabetes mellitus have not
yet been demonstrated [3]. Nonetheless, increased inﬂammatory
cells, disturbed extracellular matrix synthesis and remodeling,
and re-epithelialization problems are evident in these wounds [2].
Additionally, angiopathy and retardation of granulation tissue
formation may also be present [4]. It is suggested that cellular and
molecular signals that normally encourage wound healing are not.
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healing [5].
Currently, application of epidermal growth factor (EGF) by
various methods is the most common therapy for such wounds [6].
It is shown that recombinant human platelet derived growth factor
hastens diabetic wound closure [7]. Wang et al. [5] reported that
ﬁbroblast growth factor (FGF) along chitosan cross-linked collagen
sponge in diabetic rats accelerate healing of such wounds. Use of
vascular endothelial growth factor (VEGF) also accelerates diabetic
wound healing [8]. Recently, stem cell transplantation to chronic
wounds is favored [9]. Several researchers have evaluated effect of
adipose-derived mesenchymal stem cells in diabetic models
[3,9,10]. Since the most important cells of the skin are ﬁbroblasts
and keratinocytes [11], using of these cells also have been consid-
ered [12]. The role of ﬁbroblast in wound contraction is already
proven [13]. It has been shown that use of autologous keratinocytes
and ﬁbroblasts in pigs enhance re-epithelialization [12].
However, it is still unclear that whether transplanted cells to the
wound remain in the wound area and participate in proliferative
events or simply stimulate host cells migration. The objective of
this study was to evaluate if allogenous skin ﬁbroblast survive in
ruminant wounds, and how they affect wound healing process in
diabetic ruminant model as well.2. Materials and methods
2.1. Experimental design
Eight 4-month-old Iranian Makoui wethers weighting
25.25 ± 1.25 kg (ranging from 22 to 27 kg) at arrival were used in
this study. After diabetes induction, two excisional wounds were
created on the dorsum of each animal. Wounds of one side were
randomly chosen as treatment group (n ¼ 8), and wounds of the
other side were considered as control group (n ¼ 8). The overall
health of the wethers was monitored before and throughout the
study. The animals were kept in a barn of Veterinary Teaching
Hospital of Urmia University, Iran and were acclimatized to the
experimental conditions for 14 days. The animals had free access to
hay and tap water throughout the study. Wool of the animals was
clipped a week before surgery. Ear tags were used after local inﬁl-
trative anesthesia by 1 mL of lidocaine HCl 1% solution (Shahid
Ghazi Pharmaceutical Co, Tabriz, Iran). All experimental procedures
were approved by the Advisory Committee of the Urmia University
Research Council. None of the animals were killed or died during or
after the study.2.2. Diabetic conscious sheep model
For diabetes induction, 10% solution of alloxan monohydrate
(Sigma Aldrich Co, Dorset, UK) was infused at a dose of 60 mg/kg
into external jugular vein, after 24 h of fasting, similar to procedure
performed in dogs [14]. Alloxan was injected immediately after
dissolving in normal saline solution because of its very short half-
life in saline and blood. Diabetes establishment was conﬁrmed by
measuring blood glucose and serum insulin levels a week later.2.3. Blood glucose and serum insulin assays
Blood samples were taken in the fasted state from external ju-
gular vein in one-week intervals. Blood glucose levels were deter-
mined using glucometer device (On-Call Plus; ACON Biotech Co Ltd,
Hangzho, Zhejiang, China). Serum insulin levels were measured
using ovine insulin ELISA kit (ALPCO Diagnostics, Salem, NH, USA).2.4. Fibroblast isolation, culture and labeling
Dermal ﬁbroblasts were isolated by previously described
method [15]. Brieﬂy, skin biopsy was obtained from ear edge of a
4-month-old sheep under local inﬁltration anesthesia after
shaving and strict aseptic technique. The sample was immersed
into phosphate buffered saline (PBS) supplemented with 2% an-
tibiotics and brought to the Biotechnology Research Center of the
Urmia University within an hour. Using sterile surgical blade and
forceps, the epidermis and hypodermis were removed and the
sample was cut into 2e4 mm [2] pieces. The skin pieces were
washed two times with PBS in a Petri dish and were adhered onto
culture ﬂasks containing Dulbecco's Modiﬁed Eagle's Medium
(DMEM; Invitrogen, Grand Island, USA) supplemented with 10%
fetal bovine serum (FBS; Hyclone Labs, South Logan, USA) and 1%
antibiotics. Cells were cultured at 37 C in 5% CO2 and humidiﬁed
environment. The dishes were left undisrupted for 48 h to avoid
tissue dislodging. Thereafter, dishes were observed under inver-
ted microscope daily. The growth medium was changed every
third day. The ﬁrst overgrowth of dermal ﬁbroblasts was observed
after 3e4 days. When cultivated cells around the explants reached
to 60e80% conﬂuent, they were dissociated from dish using
trypsin solution and after centrifuging in 1200 rpm for 10 min,
were used for next passages.
For tracking the cells in the skin wounds, the cells were pre-
labeled with bromodeoxyuridine (BrdU; Sigma Aldrich Co, Ger-
many) before injection to the wounds. To do this, 10 mL of a 1 mM
BrdU working solution was added directly to each mL of tissue
culture medium after fourth sub-culture. The treated cells were
then incubated over night. Finally, cells were dissociated from
dishes as previously mentioned. Following centrifugation, the su-
pernatant was removed and the residuum of 1 mL containing cells
in PBS [13,16] was used in the wounds within 30 min. Cell count
estimated by means of a hemocytometer.2.5. Surgical wound model
After alloxan injection, a rest period of seven days for rabbits,
and 12 days for rats andmice is usually allowed to stabilize animal's
condition [17]. Two weeks after diabetes induction, the sheep's
dorsum were shaved and under local anesthesia and aseptic sur-
gical preparation, two squares measuring 2  2 cm (one square on
dorsum of each side, approximately 15 cm apart) were outlined
using a marker. Subsequently, the full-thickness demarcated areas
of skinwere removed by a scalpel. The wounds were left undressed
after hemostasis. One mL of allogenous cell suspension containing
about 106 ﬁbroblasts in PBS was injected into margins of the
treatment wounds. Control wounds received the same volume of
PBS.2.6. Planimetric analysis
Photographs were taken immediately after wounding and
after 3, 7, 10, 14 and 21 days by means of a digital camera while a
ruler was placed near the wounds. The wound areas were
analyzed by Measuring Tool of Adobe Acrobat 9 Pro Extended
software (Adobe Systems Inc, San Jose, California, USA) and
wound closure percentage was calculated using the following
formula: [18]
Percentage of wound closure ¼ ðAo  AtÞ=Ao  100;
where Ao is the original wound area and At is the wound area at the
time of imaging..
Table 1
Wound closure percentage (mean ± SD) over various times compared with ﬁrst day of wounding.
Day 3 Day 7 Day 10 Day 14 Day 21
Treatment 46.75 ± 7.08a* 45.50 ± 11.70a* 60.25 ± 3.30a* 78.75 ± 5.90b* 90.75 ± 4.50b*
Control 36.00 ± 3.74a 37.25 ± 3.94a 44.00 ± 2.82a 61.25 ± 14.93b 77.75 ± 7.76c
abc Means in the each row followed by the same letter are not signiﬁcantly different (P  0.05). Asterisk (*) indicates signiﬁcant difference (P < 0.05) between treatment and
control wounds in each time point.
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Since the proliferative phase of wound healing lasts about 21
days [19], tissue biopsies for histopathologic evaluations were
taken under local inﬁltration anesthesia after 21 days of wound
creation. The specimens were ﬁxed in 3.7% formaldehyde solution,
and embedded in parafﬁn. Five mm thickness sections were cut and
stained with hematoxylin and eosin (H&E). The slides were
assessed under light microscope for epidermal thickness, number
of ﬁbroblasts, and number of newly formed blood vessels. The
observer was blinded to the experimental design.
The thicknesses of the epidermal areas formed were measured
in ten different places along the wound surface by using a graticule
eyepiece lens and the average of these areas were taken as the
thickness of the epidermis. The number of newly formed blood
vessels and ﬁbroblasts were counted by special planimetric lens in
0.25mm2microscopic ﬁeld. Ten different areas in the sections were
counted and mean values were taken into account.
2.8. Detection of allogenous cells in the wound biopsy
To identify the transplanted cells in the wound, 5 mm thick
sections of parafﬁn embedded tissues were prepared as previously
mentioned. After routine deparafﬁnization, immunohistochemical
(IHC) staining was done using BrdU detection kit (BrdU IHC Kit;
Kamiya Biomedical Co, Seattle, WA, USA). The slides were evaluated
by light microscope.
2.9. Statistical analysis
All experimental results were presented as means ± standard
deviation (SD). Differences were considered signiﬁcant at P < 0.05.
Planimetric data were analyzes with repeated measures analysis of
variance (ANOVA) using SAS Proc Mixed software (Version 9.2, SAS
Institute Inc, Cary, NC, USA). The models included the ﬁxed effects
of treatment, day and their interactions. The models were
compared using likelihood ratio test statistic. The correlationFig. 1. Epidermal thickness (mm) of treatment and control wounds (mean ± SD). ab
different letters indicates signiﬁcant difference (P < 0.05) between the groups.structure between the repeated measures over time were exam-
ined by including SP (POW) [spatial power law], SP (GAU)
[Gaussian], and SP (SPH) [Spherical] to the model and the appro-
priate covariant structure was selected based on the lowest value of
Akaike information criterion (AIC) statistic. After ﬁtting the model,
the assumptions of normal distribution, equal variance and unusual
observations were checked using the residuals. If a signiﬁcant ﬁxed
effect was detected, differences between least squares means were
compared using the Bonferroni test. Insulin and glucose concen-
trations and histopathologic parameters were analyzed by Stu-
dent's t-test.
3. Results
Serum insulin concentration of the wethers decreased from
88.53 ± 8.17 pmol/L to 14.92 ± 7.89 pmol/L after alloxan injection
and conﬁrmed diabetes development. Blood glucose level also
increased from 3.57 ± 0.54 mmol/L to 11.06 ± 3.16 mmol/L after
diabetes induction. Both of these differences were statistically
signiﬁcant (P < 0.05). Average body weight of the animals reached
from 25.25 ± 1.25 kg at arrival to 21.75 ± 2.62 kg at the end of the
study. Additionally, polyuria was apparent several days after
alloxan administration.
As primary outcome (endpoint), wound closure percentage of
treatment and control groups over time points were measured and
could be found in Table 1. Treatment wounds were signiﬁcantly
different from control wounds on days 10 and 14 after wounding.
Furthermore, time had signiﬁcant effect on wound closure of all
wounds, as shown in table (P < 0.05).
Histopathologic parameters including epidermal thickness,
ﬁbroblast cells count and number of new blood vessels are
expressed in Figs. 1e3, respectively. All of these parameters in
treatment wounds were signiﬁcantly higher than control wounds
(P < 0.05). Not only epidermis was thicker in treatment wounds
(Fig. 4A and C), but also ﬁbroblast proliferation and collagen ﬁbers
in this group were more than control wounds (Fig. 4B and D). IHC
staining of parafﬁn embedded sections with anti-BrdU antibodyFig. 2. Number of ﬁbroblasts/0.25 mm2 (mean ± SD). ab different letters indicates
signiﬁcant difference (P < 0.05) between the groups.
Fig. 3. Number of new blood vessels/0.25 mm2 (mean ± SD). ab different letters in-
dicates signiﬁcant difference (P < 0.05) between the groups.
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wound area after 21 days of transplantation (Fig. 5). Histopatho-
logic results are the secondary outcomes of this study.4. Discussion
Crucial role of ﬁbroblast in wound healing [15], led us to
investigate its effect in compromised diabetic wound healings inFig. 4. Experimental wounds. A. Control group. Regenerated epiderm with loose texture u
group. Growing epiderm with the underlying granulation tissue. D. Treatment group. Densovine model. Although diabetes develops in sheep [20], to the best
of our knowledge, diabetic wound healing in ovine model has not
been documented. The results of this study disclosed direct effect of
allogenous transplanted ﬁbroblasts in promoting healing of skin
wounds of diabetic sheep.
Although diabetes is primarily more important in humans than
animals, much of what is known about diabetic wound healing has
been derived from experimental wounds in animals [21]. Sheep is a
model for wound repair and technologies that improve this process
[22]. Alloxan monohydrate was used to diabetes induction in the
present study. Although alloxan is the secondmost commonly used
chemical for diabetes mellitus induction, alloxan diabetes is the
best known drug-induced diabetic model. Inducing of both type I
and type II diabetes mellitus is possible with proper dosage selec-
tion of alloxan. However, for unspeciﬁed reasons, streptozotocin is
the most commonly used drug [17]. Alloxan applies speciﬁc effects
on pancreas b-cells leading to complete inhibition of the insulin
biosynthesis [23]. It forms superoxide radicals that establish a
redox cycle, and undergo dismutation to hydrogen peroxide.
Pancreas b-cells rapidly destroy by action of reactive oxygen species
with a simultaneous considerable increase in cytosolic calcium
concentration [17]. Since alloxan induced diabetes may be less
stable and reversible due to the spontaneous regeneration of b-cells
[24], we do not allowmore than twoweek period between diabetes
induction and wound creating. Accordingly, our results may
represent healing properties of acutewounds instead of the chronic
ones.nderlying tissue. B. Control group. Repaired area showing loose texture. C. Treatment
e ﬁbroblastic proliferation with collagen ﬁbers. (H&E staining).
Fig. 5. Immunohishtochemical anti-BrdU staining of allogenous ﬁbroblasts (arrows)
discloses presence of them in wound area after 21 days of transplantation.
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This hormone enhances glucose consumption in muscle and adi-
pose tissue cells and stimulates phosphorylation of glucose and
synthesis of glycogen in the liver [25]. Although vast range of
plasma insulin varying from 71.75 to 358.75 pmol/L has been re-
ported in sheep [26], and the exact amount of hypoinsulinemia
indicating diabetes has not been documented in this species as
well, our data showed apparent decrease of serum insulin level a
week after alloxan injection and wewere convinced about diabetes
development. Distinct concurrent hyperglycemia also conﬁrmed
this situation. Body weight of the animals decreased during the
study. The rationale for this weight loss may be affection of car-
bohydrate, protein, and fat metabolism with insulin deﬁciency.
Thus, muscle tissue undergoes catabolic metabolism for energy,
and protein synthesis is inhibited, resulting in muscle wasting [27].
Use of allogenous cells has some advantages compared to
autogenous cells: One can prepare these cells beforehand, whereas
biopsy taking from animal suffering from a wound for cell culture
needs much time; with this method, the problems of donor site in
injured animal are not encountered; and ﬁnally, allogenous cells
can be frozen and stored for a long time. Although, immunologic
problems and probability of rejection are themost serious concerns
of allogenous cells transplantation [28e30], the short-term survival
of allogenous ﬁbroblasts following intradermal injection is not a
signiﬁcant problem [31]. Allogenous dermal ﬁbroblasts do not
evoke an immune response, making it possible to utilize them in
skin substitutes and possibly use them for therapy. The absence of
immune response to allogenous dermal ﬁbroblasts has been
attributed to the absence of human leukocyte antigen (HLA)-DR
expression by these cells [32]. Use of the cultured ﬁbroblasts gained
from the 5th to the 10th sub-cultures is the common approach for
grafting and wound healing acceleration. By this method, surface
antigenicity of the ﬁbroblast is gradually eliminated as the number
of sub-cultures increases. However, continuing the sub-culturing
process from the 10th passage can result in chromosomal abnor-
malities [33]. In the present study, the 5th sub-culture was used to
preventing from these abnormalities.
It is reported that cultured ﬁbroblasts survive in living tissues
[13]. Our data also disclosed improvement of diabetic wound
healing by cultured allogenous ﬁbroblasts. Tracing of transplanted
pre-labeled cells by anti-BrdU staining showed that they are still
present in the wound even after 21 days of transplantation and
have not rejected. Thus, based on the results of our study,transplantation of the 5th sub-culture allogenous ﬁbroblasts in
diabetic sheep may be an appropriate method in wound therapy.
Since host cell proliferation diminishes in later stages of diabetic
wounds healing [21,34], and host ﬁbroblasts of diabetic patients
show some differences compared with normal ﬁbroblasts, such as
increased matrix metalloproteinase (MMP) synthesis that could
degrade newly formed extracellular matrix [35], it is expected
allogenous ﬁbroblasts eliminate these adverse conditions. Despite
transplanted ﬁbroblasts were present in the wound, their popula-
tion did not increase as time goes on. Other researchers have also
mentioned that transplanted ﬁbroblasts persist in a time depen-
dant manner [36,37], and their number begin to decrease after two
weeks [38]. Wound closure percentage of treatment group reached
to 90.75 ± 4.5, while control group showed only 77.75 ± 7.7 percent
of closure at the end of the study; and this difference was signiﬁ-
cant (P < 0.05). Histopathologic evaluations also revealed signiﬁ-
cantly increase of epidermal thickness, ﬁbroblast population, and
newly formed blood vessels (P < 0.05). Several researchers have
investigated role of ﬁbroblasts on wound healing. Despite Svensjo
et al. [39] found little effect of these cells on full-thickness wound
healing of normal pigs, ﬁbroblast transplantation into diabetic pigs
by Velander et al. [12] accelerated re-epithelialization. However,
they did not ﬁnd any effect on wound contraction. Our data could
be justiﬁed by the fact that ﬁbroblasts are active in proliferative
phase of healing [40], and are responsible to angiogenesis [41],
extracellular matrix and collagen synthesis, wound contraction,
and excretion of growth factors and cytokines stimulating the
wound healing [13].
Increasing in type-VII collagen by single intradermal injection of
allogeneic ﬁbroblasts in individuals with the recessive dystrophic
epidermolysis bullosa is already proven [31,37]. Considering ﬁ-
broblasts stimulate cell migration of the host by chemotaxis [19],
we can presume transplanted cells have accelerate this process in
the present study. Based on the results, it can be concluded that
allogenous skin can accelerate wound healing in alloxan diabetic
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